chlorthalidone and diazoxide

chlorthalidone has been researched along with diazoxide in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	13 (59.09)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (18.18)	29.6817
2010's	5 (22.73)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Lombardo, F; Obach, RS; Waters, NJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ	1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL	1
Koene, R; Wijdeveld, P	1
Kroneberg, G; Meng, K	1
Rawlins, MD	1
Muldowney, FP	1
Finnerty, FA	3
Bradley, P; Viktora, J; Wales, JK; Wolff, FW	1
Gulbenkian, A; Tabachnick, II; Yannell, A	1
Davidov, M; Finnerty, FA; Kakaviatos, N	1
Kern, F; Mallory, A	1
GILLENWATER, JY	1
JOHNSSON, S; LUNDVALL, O	1

Reviews

4 review(s) available for chlorthalidone and diazoxide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Variability in response to drugs. British medical journal, 1974, Oct-12, Volume: 4, Issue:5936 Topics: Acute Disease; Acylation; Chlorthalidone; Chronic Disease; Depression; Diazoxide; Digoxin; Dose-Response Relationship, Drug; Glomerulonephritis; Humans; Hypertension; Nephrotic Syndrome; Norepinephrine; Nortriptyline; Oxidation-Reduction; Phenylthiourea; Serotonin; Spironolactone; Steroids	1974
Drug-induced pancreatitis: a critical review. Gastroenterology, 1980, Volume: 78, Issue:4 Topics: Acetaminophen; Adrenal Cortex Hormones; Amphetamines; Asparaginase; Azathioprine; Chlorthalidone; Cholestyramine Resin; Cimetidine; Cyproheptadine; Dextropropoxyphene; Diazoxide; Diuretics; Estrogens; Ethacrynic Acid; Furosemide; Histamine; Humans; Hypercalcemia; Indomethacin; Isoniazid; Mercaptopurine; Narcotics; Pancreatitis; Phenformin; Procainamide; Rifampin; Salicylates; Sodium Chloride Symporter Inhibitors; Sulfonamides; Tetracycline	1980
NEWER ANTIHYPERTENSIVE DRUGS. The Medical clinics of North America, 1964, Volume: 48 Topics: Antihypertensive Agents; Chlorothiazide; Chlorthalidone; Diazoxide; Humans; Methyldopa; Reserpine; Toxicology	1964

Other Studies

18 other study(ies) available for chlorthalidone and diazoxide

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species. Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6 Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics	2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests	2013
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics. PloS one, 2016, Volume: 11, Issue:10 Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat	2016
[Diazoxide: new way in treatment of hypertension]. Nederlands tijdschrift voor geneeskunde, 1975, Mar-15, Volume: 119, Issue:11 Topics: Adult; Chlorthalidone; Diazoxide; Diet, Sodium-Restricted; Female; Humans; Hydralazine; Hypertension; Male; Methyldopa; Middle Aged; Propranolol; Tolbutamide; Water-Electrolyte Balance	1975
[Studies in the rat on the problem of the diabetogenic effect of saluretics]. Naunyn-Schmiedebergs Archiv fur experimentelle Pathologie und Pharmakologie, 1965, Sep-27, Volume: 251, Issue:5 Topics: Acetazolamide; Animals; Benzothiadiazines; Blood Glucose; Chlorthalidone; Diazoxide; Glucose Tolerance Test; Hydrochlorothiazide; Hyperglycemia; Ouabain; Potassium Chloride; Rats	1965
Management of severe hypertension. Journal of the Irish Medical Association, 1972, Dec-09, Volume: 65, Issue:23 Topics: Chlorthalidone; Coma; Debrisoquin; Diazoxide; Guanethidine; Humans; Hypertension, Malignant; Methyldopa; Nephrectomy; Pentolinium Tartrate; Renal Dialysis; Vomiting	1972
How to treat arterial hypertension. American family physician, 1973, Volume: 7, Issue:4 Topics: Antihypertensive Agents; Chlorothiazide; Chlorthalidone; Cooperative Behavior; Diazoxide; Diuretics; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Methyldopa; Physician-Patient Relations; Reserpine; Spironolactone; Sulfonamides; Triamterene	1973
Failure of repeated diazoxide injections to modify the course of severe hypertension. American heart journal, 1971, Volume: 81, Issue:5 Topics: Antihypertensive Agents; Blood Pressure; Chlorthalidone; Diazoxide; Diuretics; Guanethidine; Heart Failure; Humans; Hypertension; Kidney; Methyldopa	1971
The hyperglycemic and antidiuretic activity of a phthalimidine analogue: 1-oxo-3-(4'-chlorophenyl)-3-hydroxyisoindoline (C3-176). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1968, Volume: 128, Issue:2 Topics: Animals; Blood Glucose; Blood Pressure; Catecholamines; Chlorthalidone; Diazoxide; Diuresis; Dogs; Fasting; Fatty Acids, Nonesterified; Glucose; Hyperglycemia; In Vitro Techniques; Indoles; Injections, Intraperitoneal; Injections, Intravenous; Insulin; Male; Pancreas; Rabbits; Rats	1968
The hyperglycemic activity of benzothiadiazine and other diuretics. Life sciences, 1965, Volume: 4, Issue:20 Topics: Animals; Bendroflumethiazide; Benzothiadiazines; Chlorothiazide; Chlorthalidone; Diazoxide; Diuretics; Ethacrynic Acid; Hydroflumethiazide; Hyperglycemia; Methyclothiazide; Polythiazide; Rats; Sulfonamides; Trichlormethiazide	1965
Hypertensive vascular disease. The long term effect of rapid repeated reductions of arterial pressure with diazoxide. The American journal of cardiology, 1967, Volume: 19, Issue:3 Topics: Adult; Chlorthalidone; Diazoxide; Female; Heart Failure; Humans; Hydralazine; Hypertension; Injections, Intravenous; Male; Methyldopa; Middle Aged; Reserpine	1967
THE ANTIDIURETIC PROPERTIES OF CHLOROTHIAZIDE IN DIABETES INSIPIDUS DOGS. I. EFFECT ON SOLUTE, WATER, AND ELECTROLYTE EXCRETION. REP 582. Report. Army Medical Research Laboratory (U.S.), 1963, Jul-15 Topics: Animals; Bendroflumethiazide; Blood Volume; Body Fluids; Chlorothiazide; Chlorthalidone; Diabetes Insipidus; Diazoxide; Diuresis; Diuretics; Dogs; Electrolytes; Hydroflumethiazide; Kidney Function Tests; Pharmacology; Research; Urine; Water	1963
[INSULOMA TREATED WITH DIAZOXIDE]. Nordisk medicin, 1965, Jan-21, Volume: 73 Topics: Adenoma, Islet Cell; Antihypertensive Agents; Chlorthalidone; Diabetes Mellitus; Diazoxide; Geriatrics; Glucose Tolerance Test; Humans; Hypoglycemia; Insulinoma; Pancreatic Neoplasms	1965